Clinical trial · Interventional
Pectoral Nerve Block II and Erector Spine Plane Block in Breast Cancer Surgery
Research of the Effects of Pectoralis Nerve Block II and Erector Spina Plan Block in Breast Cancer Surgery
NCT04135157CI-TRIAL-00053359completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the analgesic effects of pectoralis nerve block (PECS II) and erector spinae plane block (ESP) in patients having segmental mastectomy and sentinel lymph node biopsy (SLNB). Each one-third of patients will have ESP block and pectoralis nerve block (PECS II) 30 min before general anesthesia , while other one-third of patients will have only general anesthesia.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Pain | — | UNRESOLVED | — |
| Analgesia | — | UNRESOLVED | — |
| Anesthesia | — | UNRESOLVED | — |
| Chronic Pain | — | UNRESOLVED | — |
| Erector Spine Plane Block | — | UNRESOLVED | — |
| Patient Controlled Analgesia | — | UNRESOLVED | — |
| Pectoralis Nerve Block | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control | Other | — | UNRESOLVED |
| Erector spine plane block | Procedure | — | UNRESOLVED |
| Pectoralis nerve block II | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- PECS II or ESP
- description
- PECS II or ESP block are performed 30 minutes before general anesthesia. PCA is used for all the patients in the first 24 hours postoperatively.
- interventionNames
- Procedure: Pectoralis nerve block II
- Procedure: Erector spine plane block
- type
- ACTIVE_COMPARATOR
- label
- Control
- description
- In the control group, patients will have only general anesthesia. PCA is used for all the patients in the first 24 hours postoperatively.
- interventionNames
- Other: Control
Primary outcomes (1)
- measure
- Opioid consumption in the first 24 hours after surgery
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * ASA 1-2 patients between the age of 18-65, scheduled for elective unilateral segmental mastectomy + sentinel lymph node biopsy Exclusion Criteria: * Age \<18 or\> 65, ASA 3-4 patients * Obesity (\> 100 kg, BMI\> 35 kg / m2) * Patients undergoing bilateral mastectomy * Pregnancy * Contraindication of regional anesthesia (coagulopathy, abnormal INR, thrombocytopenia, infection at the injection site) * Serious renal, cardiac, hepatic disease * Hypersensitivity to local anesthetics or a history of allergy * Patients with a history of opioid use longer than four weeks * Patients with psychiatric disorders or communication difficulties * Patients with chest deformity * Patients with previous breast surgery except diagnostic biopsies * Patients who do not want to participate
References
Publications (0)
Data not yet available
No reference posted for this study.